首页 > 最新文献

Future Journal of Pharmaceuticals and Health Sciences最新文献

英文 中文
A Case Study on Exercise-Induced Acute Kidney Injury - Test 运动性急性肾损伤的个案研究-试验
Pub Date : 2022-01-13 DOI: 10.26452/fjphs.v2i1.137
B. Archana
Hypouricemia is a condition which refers to hyper-uric acid clearance due to a defect in renal tubular transport. It is considered as a hereditary renal problem. Patients with hereditary renal hypouricemia have a higher risk of exercise-induced acute kidney injury and reduced kidney function. Although avoiding  exercise is considered as the best preventive measure, there are many kinds of jobs that require occupational exercise. A 32-year-old male physical trainer suffered from stage 3 Acute Kidney Injury after performing a 18-m multistage shuttle run test. His father had previously been diagnosed as having renal  hypouricemia at another facility. The patient had reported having hypouricemia during a health check, but his serum uric acid concentration was within the  normal range at our hospital. After treatment, he recovered from exercise-induced acute kidney injury and exhibited low serum uric acid and hyper-uric acid  clearance. Since the patient desired to continue his career requiring strenuous exercise, it was difficult to propose a preventive plan against the recurrence of  exercise-induced acute kidney injury. Patients suffering with hereditary renal hypouricemia are at higher risk of developing Acute Kidney Injury when undergo  strenuous occupational anaerobic exercise than other workers. Hence the risks of exercise-induced acute kidney injury among patients with hypouricemia  should be considered when undergoing physical occupational training. 
低尿酸血症是指由于肾小管运输缺陷导致的高尿酸清除。它被认为是一种遗传性肾脏疾病。遗传性肾性低尿酸血症患者发生运动性急性肾损伤和肾功能降低的风险较高。虽然避免运动被认为是最好的预防措施,但有许多种类的工作需要职业运动。一名32岁的男性体能教练在进行了18米多段穿梭跑测试后出现了3期急性肾损伤。他的父亲此前在另一家医院被诊断出患有肾性低尿酸血症。患者在健康检查中报告有低尿酸血症,但他的血清尿酸浓度在我们医院的正常范围内。治疗后,患者从运动性急性肾损伤中恢复,并表现出低血尿酸和高尿酸清除率。由于患者希望继续从事高强度运动,因此很难提出预防运动性急性肾损伤复发的方案。遗传性肾性低尿酸血症患者在进行高强度的职业性无氧运动时发生急性肾损伤的风险高于其他工人。因此,在进行体育职业训练时,应考虑低尿酸血症患者运动所致急性肾损伤的风险。
{"title":"A Case Study on Exercise-Induced Acute Kidney Injury - Test","authors":"B. Archana","doi":"10.26452/fjphs.v2i1.137","DOIUrl":"https://doi.org/10.26452/fjphs.v2i1.137","url":null,"abstract":"Hypouricemia is a condition which refers to hyper-uric acid clearance due to a defect in renal tubular transport. It is considered as a hereditary renal problem. Patients with hereditary renal hypouricemia have a higher risk of exercise-induced acute kidney injury and reduced kidney function. Although avoiding  exercise is considered as the best preventive measure, there are many kinds of jobs that require occupational exercise. A 32-year-old male physical trainer suffered from stage 3 Acute Kidney Injury after performing a 18-m multistage shuttle run test. His father had previously been diagnosed as having renal  hypouricemia at another facility. The patient had reported having hypouricemia during a health check, but his serum uric acid concentration was within the  normal range at our hospital. After treatment, he recovered from exercise-induced acute kidney injury and exhibited low serum uric acid and hyper-uric acid  clearance. Since the patient desired to continue his career requiring strenuous exercise, it was difficult to propose a preventive plan against the recurrence of  exercise-induced acute kidney injury. Patients suffering with hereditary renal hypouricemia are at higher risk of developing Acute Kidney Injury when undergo  strenuous occupational anaerobic exercise than other workers. Hence the risks of exercise-induced acute kidney injury among patients with hypouricemia  should be considered when undergoing physical occupational training. ","PeriodicalId":12614,"journal":{"name":"Future Journal of Pharmaceuticals and Health Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77850965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Original Test title 原始测试名称
Pub Date : 2022-01-13 DOI: 10.26452/fjphs.v2i1.163
Gnana Prakash
Test abstract
测试抽象
{"title":"Original Test title","authors":"Gnana Prakash","doi":"10.26452/fjphs.v2i1.163","DOIUrl":"https://doi.org/10.26452/fjphs.v2i1.163","url":null,"abstract":"Test abstract","PeriodicalId":12614,"journal":{"name":"Future Journal of Pharmaceuticals and Health Sciences","volume":"53 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90674747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2 2
Pub Date : 2021-12-06 DOI: 10.26452/fjphs.v1i4.205
G. Prakash
q
{"title":"2","authors":"G. Prakash","doi":"10.26452/fjphs.v1i4.205","DOIUrl":"https://doi.org/10.26452/fjphs.v1i4.205","url":null,"abstract":"<jats:p>q</jats:p>","PeriodicalId":12614,"journal":{"name":"Future Journal of Pharmaceuticals and Health Sciences","volume":"76 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73419278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case Report: Lamotrigine Induced Steven Johnson Syndrome 拉莫三嗪诱发史蒂文约翰逊综合征1例报告
Pub Date : 2021-10-27 DOI: 10.26452/fjphs.v1i4.202
Gnana Prakash
A 21 years old male with complaints of erythematous erosive lesions, itchy and burning sensation all over the body for 5 days and multiple erythematous maculopapular lesions on palms and soles, erosive mucosal lesions in oral mucosa, erosive erythematous lesions on the scrotum, discharge from the eye, blurring of vision and redness in both the eyes. The patient was evaluated by three local doctors but not fully diagnosed. The lesions started after taking antidepressant selective serotonin reuptake inhibitor (SSRI’S) which was Lamotrigine, along with this Aripiprazole-Atypical antidepressant and Desfenlafaxine-a serotonin and norepinephrine reuptake inhibitor (SNRI’S) was taken, it was prescribed by a psychologist who thought the patient is depressed, but the patient was inactive due to anemia. The initial dose of Lamotrigine is 25mg per day which can be managed further based on symptoms, but the patient was directly started with 100mg half tablet for 8days along with one 200mg of lamotrigine at night. The patient was not made aware of drug-related information like it’s side effects, improper drug usage and what if dose is missed. After taking patient history and examination the diagnosis was made to be Lamotrigine induced Steven Johnson syndrome (SJS). The patient was not depressed and he was not active as he was anemic. After correct diagnosis, the management was done with a corticosteroid, antihistamines, Pantoprazole, and antibiotic along with mouthwash and eye drops. The recovery period was of 40 days.
男性,21岁,主诉红斑糜烂性病变,全身发痒烧灼感5天,手掌及脚底多发黄斑丘疹病变,口腔黏膜糜烂性病变,阴囊糜烂性红斑病变,眼睛有分泌物,视力模糊,双眼发红。三名当地医生对患者进行了评估,但没有得到完全诊断。在服用抗抑郁药选择性5 -羟色胺再摄取抑制剂(SSRI 'S)即拉莫三嗪后,病变开始,同时服用阿立哌唑-非典型抗抑郁药和地芬拉法辛-一种5 -羟色胺和去甲肾上腺素再摄取抑制剂(SNRI 'S),这是由一位心理学家开的处方,他认为患者患有抑郁症,但患者因贫血而不活跃。拉莫三嗪的初始剂量为每天25mg,可根据症状进一步管理,但患者直接开始服用100mg半片,连续8天,同时夜间服用200mg拉莫三嗪。患者不知道药物相关的信息,如副作用,不正确的药物使用以及如果错过剂量会怎样。经查阅病史和检查,诊断为拉莫三嗪诱发的史蒂文约翰逊综合征(SJS)。病人并不抑郁,也不活跃,因为他贫血。正确诊断后,使用皮质类固醇、抗组胺药、泮托拉唑、抗生素以及漱口水和滴眼液进行治疗。恢复期为40天。
{"title":"A Case Report: Lamotrigine Induced Steven Johnson Syndrome","authors":"Gnana Prakash","doi":"10.26452/fjphs.v1i4.202","DOIUrl":"https://doi.org/10.26452/fjphs.v1i4.202","url":null,"abstract":"A 21 years old male with complaints of erythematous erosive lesions, itchy and burning sensation all over the body for 5 days and multiple erythematous maculopapular lesions on palms and soles, erosive mucosal lesions in oral mucosa, erosive erythematous lesions on the scrotum, discharge from the eye, blurring of vision and redness in both the eyes. The patient was evaluated by three local doctors but not fully diagnosed. The lesions started after taking antidepressant selective serotonin reuptake inhibitor (SSRI’S) which was Lamotrigine, along with this Aripiprazole-Atypical antidepressant and Desfenlafaxine-a serotonin and norepinephrine reuptake inhibitor (SNRI’S) was taken, it was prescribed by a psychologist who thought the patient is depressed, but the patient was inactive due to anemia. The initial dose of Lamotrigine is 25mg per day which can be managed further based on symptoms, but the patient was directly started with 100mg half tablet for 8days along with one 200mg of lamotrigine at night. The patient was not made aware of drug-related information like it’s side effects, improper drug usage and what if dose is missed. After taking patient history and examination the diagnosis was made to be Lamotrigine induced Steven Johnson syndrome (SJS). The patient was not depressed and he was not active as he was anemic. After correct diagnosis, the management was done with a corticosteroid, antihistamines, Pantoprazole, and antibiotic along with mouthwash and eye drops. The recovery period was of 40 days.","PeriodicalId":12614,"journal":{"name":"Future Journal of Pharmaceuticals and Health Sciences","volume":"44 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74351388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formulation Design and Evaluation of Olmesartan Mucoadhesive Buccal Tablets 奥美沙坦黏附口腔片的配方设计与评价
Pub Date : 2021-10-09 DOI: 10.26452/fjphs.v1i4.184
Gnana Prakash
The present study mucoadhesive buccal tablets of Olmesartan can be used to bypass the extensive hepatic first-pass metabolism and improve the bioavailability. The mucoadhesive Buccal tablets of Olmesartan are a drug of choice in the treatment of high blood pressure, heart failure, and diabetic kidneys. The FTIR results revealed that there was no interaction between drugs and other excipients. All the post-compression parameter was within acceptable limits. The in vitro drug release was in the range of 85.35% to 99.65% after 8 hrs the very best regression integrity (r) the best fit role model for F1 to F8 used to be zero-order and for F9 it was Higuchi matrix.
本研究表明奥美沙坦黏附含片可绕过肝脏广泛的首过代谢,提高生物利用度。黏附奥美沙坦口腔片是治疗高血压、心力衰竭和糖尿病肾病的首选药物。FTIR结果显示药物与其他赋形剂之间没有相互作用。所有后压缩参数均在可接受范围内。8 h体外释药范围为85.35% ~ 99.65%,最佳回归完整性(r)为零阶模型,F9为Higuchi矩阵模型。
{"title":"Formulation Design and Evaluation of Olmesartan Mucoadhesive Buccal Tablets","authors":"Gnana Prakash","doi":"10.26452/fjphs.v1i4.184","DOIUrl":"https://doi.org/10.26452/fjphs.v1i4.184","url":null,"abstract":"The present study mucoadhesive buccal tablets of Olmesartan can be used to bypass the extensive hepatic first-pass metabolism and improve the bioavailability. The mucoadhesive Buccal tablets of Olmesartan are a drug of choice in the treatment of high blood pressure, heart failure, and diabetic kidneys. The FTIR results revealed that there was no interaction between drugs and other excipients. All the post-compression parameter was within acceptable limits. The in vitro drug release was in the range of 85.35% to 99.65% after 8 hrs the very best regression integrity (r) the best fit role model for F1 to F8 used to be zero-order and for F9 it was Higuchi matrix.","PeriodicalId":12614,"journal":{"name":"Future Journal of Pharmaceuticals and Health Sciences","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84885201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Development and Pre-Clinical Evaluation of Polyherbal Hand Wash 复方洗手液的研制及临床前评价
Pub Date : 2021-10-09 DOI: 10.26452/fjphs.v1i4.176
Gnana Prakash
Hand-washing is significant in agriculture, housekeeping, and in addition vital in houses and daycare plans. The artificial handwash formulations an effort antiquated entice formulate a polyherbal hand wash victimization extract of Sida cardifolia, Azadirachta indica, aloe vera gel, and lemon juice. The pH of hand wash was ranging from 6.36 to 6.88. The handwash formulations were ranges from 56 cp to 62 cp. The formulation planned out along with lemon juice displayed the best antimicrobial utilization than the formulation while not lemon juice. The stableness reports no change in pH & Viscosity referred to in the formulations. The effects of the present work support the internalization as well as utilization of herbs in the formulation to help give better results.
洗手在农业和家务中很重要,而且在家庭和日托计划中也很重要。人工洗手液配方是一种古老的配方,它是一种多草药洗手液的萃取物,包括Sida cardifolia、印楝、芦荟凝胶和柠檬汁。洗手液pH值为6.36 ~ 6.88。洗手液配方在56 ~ 62 cp范围内,与柠檬汁一起计划的配方抗菌效果最好,而不是柠檬汁。稳定性报告没有改变配方中提到的pH和粘度。本研究的结果支持了制剂中草药的内化和利用,以帮助获得更好的效果。
{"title":"Development and Pre-Clinical Evaluation of Polyherbal Hand Wash","authors":"Gnana Prakash","doi":"10.26452/fjphs.v1i4.176","DOIUrl":"https://doi.org/10.26452/fjphs.v1i4.176","url":null,"abstract":"Hand-washing is significant in agriculture, housekeeping, and in addition vital in houses and daycare plans. The artificial handwash formulations an effort antiquated entice formulate a polyherbal hand wash victimization extract of Sida cardifolia, Azadirachta indica, aloe vera gel, and lemon juice. The pH of hand wash was ranging from 6.36 to 6.88. The handwash formulations were ranges from 56 cp to 62 cp. The formulation planned out along with lemon juice displayed the best antimicrobial utilization than the formulation while not lemon juice. The stableness reports no change in pH & Viscosity referred to in the formulations. The effects of the present work support the internalization as well as utilization of herbs in the formulation to help give better results.","PeriodicalId":12614,"journal":{"name":"Future Journal of Pharmaceuticals and Health Sciences","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74049633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perception of rural and urban population on generic and branded drugs 城乡人口对仿制药和品牌药的认知
Pub Date : 2021-10-09 DOI: 10.26452/fjphs.v1i4.175
Gnana Prakash
Generic medicines are identical/ clone to an innovator or product brand name. After expiration of patent terms of the innovator product, other pharmaceutical companies usually apply to the drug regulatory bodies for approval to market the generic versions of the innovator's drugs. Generic drugs in the market were sold under the non-proprietary name or brand name. Drugs and medicines form a significant portion of out of pocket (OOP) expenses in Indian households. In order to resolve this issue, Government of India launched Jan Aushadhi Scheme (JAS) to provide inexpensive generic drugs to the patients. A separate interview was conducted for the illiterate people and Google forms were forwarded through whatsapp for literates, both contain the same questions to exclude the bias. The collected data was analysed and converted to graphs/ pie charts and the collected data was documented. Our study concludes that by using the questionnaire, the total patients (n= 500) were interviewed, different ages of people were included(15 to above 50).15-30 age group 29.2%, 31-49 age group 39.8%, above 50 age group 31% were involved. Male 60.4%, Female 39.4%, literate 47.4%, illiterate 52.6%, rural 49%, urban 51% were involved. A standard survey form/data collection sheet for both rural and urban population was used. Both literates and illiterates in rural and urban population almost 49% preferred branded drugs due to brand trust, quality, efficacy, and nearly 38% purchase medications based on the availability and remaining 13% preferred generic due to various reasons like cost effectiveness, same as branded quality and effectiveness.
仿制药与创新者或产品品牌名称相同/克隆。在创新产品的专利期限到期后,其他制药公司通常会向药品监管机构申请批准,以销售创新药物的仿制药。市场上的仿制药以非专利名称或品牌名称销售。药品和药品构成了印度家庭自费支出的很大一部分。为了解决这一问题,印度政府启动了Jan Aushadhi计划(JAS),为患者提供廉价的仿制药。对不识字的人进行了单独的采访,谷歌表格通过whatsapp转发给识字的人,两者都包含相同的问题以排除偏见。对收集到的数据进行分析并转换成图形/饼状图,并记录收集到的数据。我们的研究得出结论,通过问卷调查,共采访了500例患者,包括不同年龄的人群(15岁至50岁以上)。15-30岁年龄组29.2%,31-49岁年龄组39.8%,50岁以上年龄组31%。男性60.4%,女性39.4%,识字47.4%,文盲52.6%,农村49%,城市51%。使用了标准的农村和城市人口调查表/数据收集表。城乡文盲中有近49%的人出于对品牌信任、质量、疗效的考虑而选择品牌药,近38%的人基于可获得性购买药品,剩余13%的人出于成本效益等各种原因而选择仿制药,与品牌药的质量和疗效相同。
{"title":"Perception of rural and urban population on generic and branded drugs","authors":"Gnana Prakash","doi":"10.26452/fjphs.v1i4.175","DOIUrl":"https://doi.org/10.26452/fjphs.v1i4.175","url":null,"abstract":"Generic medicines are identical/ clone to an innovator or product brand name. After expiration of patent terms of the innovator product, other pharmaceutical companies usually apply to the drug regulatory bodies for approval to market the generic versions of the innovator's drugs. Generic drugs in the market were sold under the non-proprietary name or brand name. Drugs and medicines form a significant portion of out of pocket (OOP) expenses in Indian households. In order to resolve this issue, Government of India launched Jan Aushadhi Scheme (JAS) to provide inexpensive generic drugs to the patients. A separate interview was conducted for the illiterate people and Google forms were forwarded through whatsapp for literates, both contain the same questions to exclude the bias. The collected data was analysed and converted to graphs/ pie charts and the collected data was documented. Our study concludes that by using the questionnaire, the total patients (n= 500) were interviewed, different ages of people were included(15 to above 50).15-30 age group 29.2%, 31-49 age group 39.8%, above 50 age group 31% were involved. Male 60.4%, Female 39.4%, literate 47.4%, illiterate 52.6%, rural 49%, urban 51% were involved. A standard survey form/data collection sheet for both rural and urban population was used. Both literates and illiterates in rural and urban population almost 49% preferred branded drugs due to brand trust, quality, efficacy, and nearly 38% purchase medications based on the availability and remaining 13% preferred generic due to various reasons like cost effectiveness, same as branded quality and effectiveness.","PeriodicalId":12614,"journal":{"name":"Future Journal of Pharmaceuticals and Health Sciences","volume":"105 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80901150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Comparative Study on Effectiveness of Various Extraction Techniques Affecting the Anti-Oxidant Property of Anethum graveolens 不同提取工艺对茴香抗氧化性能影响的比较研究
Pub Date : 2021-10-09 DOI: 10.26452/fjphs.v1i4.201
Gnana Prakash
In this research, Anethum graveolens which is an aromatic plant that contains essential oils which have non-polar and polar components which are evaluated for their anti-oxidant property through in-vitro assays. Herbs have different chemical constituents that include the unique functions of ownership of different pharmacological activities. Extraction is the technique to extract the active constituents and phytochemical lead moiety from the crude plant. Anethum graveolens is an aromatic herb used in herbal medicine in India. An excess of flavonoids is known to have antioxidant properties in this herb. Traditionally has been used to cure and avoid illness, and the natural compounds in the plant have been used to treat other diseases. Anethum graveolens aerial parts of the plant have been extracted by using ethanol and chloroform by three separate extraction methods such as Soxhletion, Ultra-sound, and Microwave have been performed. Ultrasonic extraction was found to be the best extraction method, and ethanol was found to be the best solvent for flavonoids. Thus having a good antioxidant property.
在本研究中,菊花是一种芳香植物,它含有非极性和极性成分的精油,通过体外试验评估了它们的抗氧化性能。草药具有不同的化学成分,包括独特的功能,拥有不同的药理活性。提取是指从粗植物中提取有效成分和植物化学铅的技术。茴香是印度草药中使用的一种芳香草药。已知这种草药中过量的类黄酮具有抗氧化特性。传统上,它被用来治疗和避免疾病,而植物中的天然化合物也被用来治疗其他疾病。以乙醇和氯仿为原料,采用索氏提取法、超声波提取法和微波提取法三种不同的提取方法,分别提取了石蒜的地上部分。超声波是提取黄酮类化合物的最佳方法,乙醇是提取黄酮类化合物的最佳溶剂。因此具有良好的抗氧化性能。
{"title":"A Comparative Study on Effectiveness of Various Extraction Techniques Affecting the Anti-Oxidant Property of Anethum graveolens","authors":"Gnana Prakash","doi":"10.26452/fjphs.v1i4.201","DOIUrl":"https://doi.org/10.26452/fjphs.v1i4.201","url":null,"abstract":"\u0000In this research, Anethum graveolens which is an aromatic plant that contains essential oils which have non-polar and polar components which are evaluated for their anti-oxidant property through in-vitro assays. Herbs have different chemical constituents that include the unique functions of ownership of different pharmacological activities. Extraction is the technique to extract the active constituents and phytochemical lead moiety from the crude plant. Anethum graveolens is an aromatic herb used in herbal medicine in India. An excess of flavonoids is known to have antioxidant properties in this herb. Traditionally has been used to cure and avoid illness, and the natural compounds in the plant have been used to treat other diseases. Anethum graveolens aerial parts of the plant have been extracted by using ethanol and chloroform by three separate extraction methods such as Soxhletion, Ultra-sound, and Microwave have been performed. Ultrasonic extraction was found to be the best extraction method, and ethanol was found to be the best solvent for flavonoids. Thus having a good antioxidant property. \u0000","PeriodicalId":12614,"journal":{"name":"Future Journal of Pharmaceuticals and Health Sciences","volume":"53 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91226546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Formulation and In Vitro/In Vivo Evaluation of Metoclopramide Mucoadhesive Buccal Patches for Effective Pain Management 甲氧氯普胺黏附口腔贴片的配方及体外/体内评价对疼痛的有效控制
Pub Date : 2021-10-09 DOI: 10.26452/fjphs.v1i4.190
Gnana Prakash
The report planned to design plus valuate mucoadhesive buccal patches of Metoclopramide for orthopedic treatment of pain and inflammations. All eight formulation acquire numerous evaluation parameters, it used to be complete for which F1 confirmed good mucoadhesive strength, encouraging pressurized and arrant drug release, easiest In-vivo residence time, swelling index and pH shows the best formulation. The acquired in vivo effects show that the put concentration of Metoclopramide in the mouth cavity was retained above 5 pg/mE for 130 min. The effect stands for so the buccal patches of metoclopramide could be a good choice to avoid the unsatisfactory systemic unwanted effects and will be planned as a new therapeutic tool around against orthopedic diseases and disturbances.
本报告计划设计并评估甲氧氯普胺黏附口腔贴片用于骨科治疗疼痛和炎症的效果。8种制剂均获得了众多的评价参数,其中F1证实黏附强度好,有利于加压和平稳释放药物,最易体内停留时间、溶胀指数和pH值为最佳制剂。获得的体内效应表明,甲氧氯普胺在口腔内的浓度保持在5pg /mE以上,持续时间为130 min。结果表明,甲氧氯普胺口腔贴片是一种良好的选择,可以避免全身不良反应,有望成为一种新的治疗骨科疾病和紊乱的工具。
{"title":"Formulation and In Vitro/In Vivo Evaluation of Metoclopramide Mucoadhesive Buccal Patches for Effective Pain Management","authors":"Gnana Prakash","doi":"10.26452/fjphs.v1i4.190","DOIUrl":"https://doi.org/10.26452/fjphs.v1i4.190","url":null,"abstract":"The report planned to design plus valuate mucoadhesive buccal patches of Metoclopramide for orthopedic treatment of pain and inflammations. All eight formulation acquire numerous evaluation parameters, it used to be complete for which F1 confirmed good mucoadhesive strength, encouraging pressurized and arrant drug release, easiest In-vivo residence time, swelling index and pH shows the best formulation. The acquired in vivo effects show that the put concentration of Metoclopramide in the mouth cavity was retained above 5 pg/mE for 130 min. The effect stands for so the buccal patches of metoclopramide could be a good choice to avoid the unsatisfactory systemic unwanted effects and will be planned as a new therapeutic tool around against orthopedic diseases and disturbances.","PeriodicalId":12614,"journal":{"name":"Future Journal of Pharmaceuticals and Health Sciences","volume":"35 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80744949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clotrimazole Loaded Topical Gels: Formulation, Development and In-vitro Evaluation 氯霉唑外用凝胶:配方、开发和体外评价
Pub Date : 2021-10-09 DOI: 10.26452/fjphs.v1i4.174
Gnana Prakash
The present study aimed to formulate and evaluate clotrimazole topical gel. Clotrimazole topical gel was prepared by dispersion method by utilizing various gelling agents like Carbopol 934p, HPMC K100, and Sodium alginate in three different ratios to achieve desired drug release. Prepared six gel formulations of clotrimazole were evaluated for pH, Viscosity, Drug content, Drug diffusion studies, and Drug release kinetic studies. The Drug-polymer compatibility reports have been done by FTIR absences of extraneous interactions among excipients. CTZGF4 releases 99.53% of the drug at the end of 8 hours and was considered as the best formulation. Therefore, formulations containing Carbopol produced better results than other formulations.
本研究旨在制备并评价克霉唑外用凝胶。以卡波尔934p、HPMC K100、海藻酸钠为胶凝剂,按三种不同的配比,采用分散法制备克霉唑外用凝胶,达到理想的释药效果。对制备的六种氯霉唑凝胶制剂进行了pH、粘度、药物含量、药物扩散研究和药物释放动力学研究。药物-聚合物相容性报告是通过FTIR完成的,没有辅料之间的外来相互作用。8 h时CTZGF4释药率为99.53%,为最佳处方。因此,含有卡波波尔的配方比其他配方产生更好的效果。
{"title":"Clotrimazole Loaded Topical Gels: Formulation, Development and In-vitro Evaluation","authors":"Gnana Prakash","doi":"10.26452/fjphs.v1i4.174","DOIUrl":"https://doi.org/10.26452/fjphs.v1i4.174","url":null,"abstract":"The present study aimed to formulate and evaluate clotrimazole topical gel. Clotrimazole topical gel was prepared by dispersion method by utilizing various gelling agents like Carbopol 934p, HPMC K100, and Sodium alginate in three different ratios to achieve desired drug release. Prepared six gel formulations of clotrimazole were evaluated for pH, Viscosity, Drug content, Drug diffusion studies, and Drug release kinetic studies. The Drug-polymer compatibility reports have been done by FTIR absences of extraneous interactions among excipients. CTZGF4 releases 99.53% of the drug at the end of 8 hours and was considered as the best formulation. Therefore, formulations containing Carbopol produced better results than other formulations.","PeriodicalId":12614,"journal":{"name":"Future Journal of Pharmaceuticals and Health Sciences","volume":"64 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90202834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Future Journal of Pharmaceuticals and Health Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1